Revision: March 18, 2025, 9:01 a.m.
Rep. Mazur, Hills. 44
Rep. Layon, Rock. 13
Rep. Reinfurt, Hills. 29
March 17, 2025
2025-1049h
11/05
Floor Amendment to HB 377-FN
Amend the bill by replacing all after section 1 with the following:
2 New Chapter; Prohibiting Medical Procedures and Treatments Intended to Alter a Minor's Gender or Puberty. Amend RSA by inserting after chapter 332-M the following new chapter:
CHAPTER 332-N
PROHIBITING MEDICAL PROCEDURES AND TREATMENTS INTENDED TO ALTER A MINOR'S GENDER OR PUBERTY
332-N:1 Definitions. As used in this chapter:
I. "Biological sex" shall mean the male and female biological sexes.
II. "Minor" means a person under 18 years of age.
III. "Person" includes any of the following:
(a) Any individual.
(b) Any agent, employee, official, or contractor of any legal entity.
(c) Any agent, employee, official, or contractor of a school district or the state or any of its political subdivisions or agencies.
332-N:2 Prohibitions for Health Care Providers.
I. Except as provided in paragraphs II and III, a person shall not knowingly perform or offer to perform on a minor, or administer or offer to administer to a minor, a medical procedure, including but not limited to a puberty-blocking or cross-sex hormone medication, if the performance or administration of the procedure or medication is for the purpose of altering or attempting to alter the appearance of or affirm the minor's perception of his or her gender or sex, if that perception is inconsistent with the minor's biological sex as defined in this chapter:
(a) Enabling a minor to identify with, or live as, a purported identity inconsistent with the minor's biological sex; or
(b) Treating purported discomfort or distress from a discordance between the minor's biological sex and asserted identity.
II. Paragraph I shall not apply to a procedure undertaken to treat a minor born with a medically verifiable disorder of sex development as defined in RSA 332-M:2, II.
III. Paragraph I shall not apply to a health care provider who, having prescribed a course of treatment to a minor prior to the effective date of this section that includes the delivery or administration of puberty-blocking or cross-sex hormone medications, determines and documents in the minor's medical record that immediate termination of the minor's use of the puberty-blocking or cross-sex hormone medications or drugs would cause harm to the minor, and institutes a systematic reduction or tapering of puberty-blocking or cross-sex hormone medications or drugs that shall conclude prior to January 1, 2026.
IV. A violation of this section is a class B felony.
3 Prospective Repeal. RSA 332-N:2, III, relative to systematic reduction and tapering of puberty-blocking or cross-sex hormone medications, is repealed.
I. Section 3 of this act shall take effect January 1, 2026.
II. The remainder of this act shall take effect upon its passage.
2025-1049h
AMENDED ANALYSIS
This bill prohibits the performance of a medical procedure or the prescription or issuance of medication, upon or to a minor child, that is intended to alter the minor child's gender or delay puberty. This bill also provides for a limited period in which a health care provider may systematically reduce or taper puberty-blocking or cross-sex hormone medications or drugs to avoid harm to a minor already receiving treatment.